Hindustan Zinc Falls, Pharma Slumps, MCX Hits Record High
Written by - Fisdom Research
Array
June 17, 2025
2 minutes
Array
Market Snapshot
Indian equity markets closed lower on June 17, giving up part of the previous session’s gains amid heightened volatility.
Geopolitical tensions in the Middle East weighed on investor sentiment, leading to cautious trading.
Broader markets underperformed, with the BSE Midcap and Smallcap indices each declining by 0.5%.
Sectorally, the Nifty Pharma index dropped 2% following reports that U.S. President Donald Trump hinted at imposing new tariffs on pharmaceutical imports.
Sectoral Trends
Sector Name
% Change
Sector Name
% Change
NIFTY IT
0.7
NIFTY REALTY
-0.7
NIFTY FMCG
-0.3
NIFTY MEDIA
-0.7
NIFTY PRIVATE BANK
-0.4
NIFTY PSU BANK
-0.7
NIFTY AUTO
-0.6
NIFTY CONSUMER DURABLES
-0.7
Top News
Hindustan Zinc shares fell 4% after announcing a ₹12,000 crore capex plan to set up an integrated zinc metal complex in Rajasthan as part of its capacity expansion.
Pharma stocks declined sharply, with the Nifty Pharma index dropping nearly 2%, after U.S. President Donald Trump warned of upcoming tariffs on pharmaceutical imports, raising concerns for Indian exporters.
MCX gained around 2.5% to hit a record high following reports that the exchange plans to launch electricity derivatives later this year, having already secured SEBI’s approval.
Top Gainers and Losers
Top Gainers
% Change
Top Losers
% Change
TECHM
1.7
ADANIENT
-2.3
INFY
0.9
ETERNAL
-2.1
ASIANPAINT
0.9
DRREDDY
-2.0
Technical Outlook: Key Indices
Indices Name
Support
Resistance
Nifty
24,700
25,200
Bank Nifty
55,500
56,500
Trade Ideas Update
Our trade ideas success rate has 64% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.
